Join
Live feed
·
INSIDERFilingvia Quantisnow
Mineralys Therapeutics Inc. logo

Chief Executive Officer Congleton Jon sold $1,960,601 worth of shares (75,000 units at $26.14) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 614,321 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MLYS· Mineralys Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MLYS (Mineralys Therapeutics Inc.) and more on Quantisnow.